Core Insights - The company, Guoshengtang (02273), reported a total of approximately 1.607 million patient visits for the three months ending September 30, 2025, representing an increase of about 8.2% compared to the same period in 2024 [1] Company Performance - Total patient visits reached approximately 1.607 million [1] - Year-over-year growth in patient visits is approximately 8.2% [1]

Core Viewpoint - The company reported a total of approximately 1.607 million patient visits for the three months ending September 30, 2025, representing an increase of about 8.2% compared to the same period in 2024 [1] Company Summary - The total number of patient visits for the company reached approximately 1.607 million [1] - This figure indicates a growth rate of approximately 8.2% year-over-year [1]

Core Insights - The company, Guoshengtang (02273.HK), reported operational data for the three months ending September 30, 2025, indicating a total of approximately 1.607 million patient visits, which represents an increase of about 8.2% compared to the same period in 2024, where there were approximately 1.485 million patient visits [1] Summary by Category - **Operational Performance** - Total patient visits for the three months ending September 30, 2025, were approximately 1.607 million, reflecting an 8.2% growth year-over-year from approximately 1.485 million visits in 2024 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 GUSHENGTANG HOLDINGS LIMITED 固 生 堂 控 股 有 限 公 司 固生堂控股有限公司 （根據開曼群島法律註冊成立的有限公司） （股份代號：2273） 自願性公告 截至2025年9月30日止三個月之經營數據 本公告乃由固生堂控股有限公司（「本公司」）自願作出，旨在向本公司股東及 有意投資者提供截至2025年9月30日止三個月之本集團最新業務發展。 截至2025年9月30日止三個月的客戶就診人次總數約為1,607,000，較2024年同期 （約1,485,000客戶就診人次）增長約8.2%。 上述經營數據乃基於本公司的記錄，未經本公司核數師審核或審閱。經營數據 可能與相關定期報告所披露者有所不同。如有任何不一致，概以相關定期報告 所披露之經營數據為準。 本公司股東及有意投資者於買賣本公司股份時務請審慎行事。如有任何疑問， 投資者應尋求專業人士或財務顧問的專業意見。 GUSHENG ...

Group 1 - The company, Guoshengtang (02273.HK), announced a share buyback on October 31, 2023, spending HKD 16.5874 million to repurchase 582,000 shares [1] - The buyback price per share ranged from HKD 28.34 to HKD 28.68 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 固生堂控股有限公司 呈交日期： 2025年10月31日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02273 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | | 庫存 ...

Summary of Key Points Core Viewpoint - On October 30, 32 Hong Kong-listed companies conducted share buybacks, totaling 34.66 million shares and an aggregate amount of HKD 155 million [1][2]. Group 1: Buyback Details - China Feihe repurchased 12 million shares for HKD 50.23 million, with a highest price of HKD 4.200 and a lowest price of HKD 4.170, bringing its total buyback amount for the year to HKD 129 million [1][2]. - China Petroleum & Chemical Corporation repurchased 4.78 million shares for HKD 19.72 million, with a highest price of HKD 4.220 and a lowest price of HKD 4.100, accumulating a total buyback amount of HKD 794 million for the year [1][2]. - Stone Four Pharmaceutical Group repurchased 5 million shares for HKD 15.41 million, with a highest price of HKD 3.130 and a lowest price of HKD 3.030, totaling HKD 14.81 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 30 was from China Feihe at HKD 50.23 million, followed by China Petroleum & Chemical Corporation at HKD 19.72 million [1][2]. - In terms of share quantity, China Feihe led with 12 million shares repurchased, followed by Stone Four Pharmaceutical Group with 5 million shares and China Petroleum & Chemical Corporation with 4.78 million shares [1][2]. Group 3: Additional Buyback Information - Other notable companies involved in buybacks include Lianlian Digital and Guosheng Tang, with varying amounts and share quantities [1][2]. - The data also includes a detailed table of buybacks from various companies, highlighting their respective share counts, amounts, and price ranges [2][3].

Core Insights - A total of 30 companies conducted share buybacks on October 30, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent [1][2] - The total buyback amount for China Feihe was 50.23 million yuan, with 12 million shares repurchased, representing a significant investment in its own stock [1][2] Summary by Company - **China Feihe (06186)**: Repurchased 12 million shares for 50.23 million yuan; cumulative buybacks for the year reached 30.95 million shares, accounting for 0.341% of total share capital [2] - **China Petroleum & Chemical Corporation (00386)**: Repurchased 4.78 million shares for 19.72 million yuan; cumulative buybacks for the year reached 102 million shares, accounting for 0.080% of total share capital [2] - **Stone Four Pharmaceutical Group (02005)**: Repurchased 5 million shares for 15.41 million yuan; cumulative buybacks for the year reached 44.20 million shares, accounting for 1.498% of total share capital [2] - **Lianlian Digital (02598)**: Repurchased 1.38 million shares for 11.31 million yuan; cumulative buybacks for the year reached 4.45 million shares, accounting for 1.065% of total share capital [2] - **Gushengtang (02273)**: Repurchased 290,100 shares for 8.33 million yuan; cumulative buybacks for the year reached 5.88 million shares, accounting for 2.482% of total share capital [2] - **Lianyi Technology-W (09959)**: Repurchased 2.3 million shares for 7.42 million yuan; cumulative buybacks for the year reached 80.04 million shares, accounting for 3.746% of total share capital [2] - **Mongolian Dairy (02319)**: Repurchased 400,000 shares for 5.70 million yuan; cumulative buybacks for the year reached 22.42 million shares, accounting for 0.573% of total share capital [2] - **Kangchen Pharmaceutical (01681)**: Repurchased 280,000 shares for 4.21 million yuan; cumulative buybacks for the year reached 7.84 million shares, accounting for 9.216% of total share capital [2] - **Other Companies**: Various other companies also participated in buybacks, with amounts ranging from 4.51 million yuan to 6 million yuan, and share counts varying significantly [2]

Core Points - The company Gushengtang has been actively repurchasing its shares, with a total of 558,980 shares bought back since September 10, amounting to HKD 173 million [2] - The stock price has seen a decline of 14.27% during the repurchase period, with the latest closing price at HKD 28.540, down 2.33% on the day of the latest buyback [2] - Year-to-date, Gushengtang has conducted 57 repurchase transactions, totaling 854,440 shares and an expenditure of HKD 267 million [2] Repurchase Details - On October 30, 2025, Gushengtang repurchased 29,010 shares at a price range of HKD 28.460 to HKD 29.080, with a total repurchase amount of HKD 8.3254 million [2] - The highest repurchase price during the recent buyback was HKD 29.320 on October 28, while the lowest was HKD 28.460 on October 30 [3] - The company has consistently repurchased shares over the past 34 days, indicating a strong commitment to supporting its stock price [2][3]

Group 1 - The company, Guoshengtang (02273), announced a share buyback plan on October 30, 2025, involving an expenditure of HKD 8.3254 million to repurchase 290,100 shares [1] - The repurchase price per share ranged from HKD 28.46 to HKD 29.08 [1]